Back
Prothena Corp. Plc 10K Form
Sell
31
PRTA
Prothena Corp. Plc
Last Price:
$9.02
Seasonality Move:
-3.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2024-02-22 | 10K | PRTA/Prothena Corp. Plc Annual |
| 2023-11-02 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-08-03 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-05-04 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-02-28 | 10K | PRTA/Prothena Corp. Plc Annual |
Receive PRTA News And Ratings
See the #1 stock for the next 7 days that we like better than PRTA
PRTA Financial Statistics
Sales & Book Value
| Annual Sales: | $9.7M |
|---|---|
| Cash Flow: | $-43.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.21 |
| Price / Book: | 1.73 |
Profitability
| EPS (TTM): | -4.53460 |
|---|---|
| Net Income (TTM): | $-244.1M |
| Gross Margin: | $0 |
| Return on Equity: | -66.9% |
| Return on Assets: | -57.54% |
Prothena Corp. Plc Earnings Forecast
Key Prothena Corp. Plc Financial Ratios
-
The Gross Profit Margin over the past 16 years for PRTA is 0.00%.
-
The Selling, General & Administrative Expenses for PRTA have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 1,392.52% of Revenue.
-
The Net Earning history of PRTA is -2,520.57% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 7 years.
Prothena Corp. Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PRTA |
| CUSIP: | G72800 |
| Website: | prothena.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 7.72 |
| Quick Ratio: | 7.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 17.68 |
PRTA Technical Analysis vs Fundamental Analysis
Sell
31
Prothena Corp. Plc (PRTA)
is a Sell
Is Prothena Corp. Plc a Buy or a Sell?
-
Prothena Corp. Plc stock is rated a SellThe current Prothena Corp. Plc [PRTA] share price is $9.02. The Score for PRTA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.